These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Significance of positive and inhibitory regulators in the TGF-β signaling pathway in colorectal cancers. Coates RF; Gardner JA; Gao Y; Cortright VM; Mitchell JM; Ashikaga T; Skelly J; Yang MX Hum Pathol; 2017 Aug; 66():34-39. PubMed ID: 28601657 [TBL] [Abstract][Full Text] [Related]
3. [Relationship between Expression of TGF-β1, Smad2, Smad4 and Prognosis of Patients with Resected Non-small Cell Lung Cancer]. Xie M; He C; Wei S Zhongguo Fei Ai Za Zhi; 2015 Sep; 18(9):543-8. PubMed ID: 26383977 [TBL] [Abstract][Full Text] [Related]
4. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients. Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677 [TBL] [Abstract][Full Text] [Related]
5. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma. Fan J; Yang MX; Ouyang Q; Fu D; Xu Z; Liu X; Mino-Kenudson M; Geng J; Tang F Hum Pathol; 2016 Sep; 55():151-8. PubMed ID: 27195906 [TBL] [Abstract][Full Text] [Related]
7. TGF-β1, Smad-2/-3, Smad-1/-5/-8, and Smad-4 signaling factors are expressed in ameloblastomas, adenomatoid odontogenic tumors, and calcifying cystic odontogenic tumors: an immunohistochemical study. Karathanasi V; Tosios KI; Nikitakis NG; Piperi E; Koutlas I; Trimis G; Sklavounou A J Oral Pathol Med; 2013 May; 42(5):415-23. PubMed ID: 23157422 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer. Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802 [TBL] [Abstract][Full Text] [Related]
9. The prognostic role of TGF-β signaling pathway in breast cancer patients. de Kruijf EM; Dekker TJA; Hawinkels LJAC; Putter H; Smit VTHBM; Kroep JR; Kuppen PJK; van de Velde CJH; Ten Dijke P; Tollenaar RAEM; Mesker WE Ann Oncol; 2013 Feb; 24(2):384-390. PubMed ID: 23022998 [TBL] [Abstract][Full Text] [Related]
10. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. Xiangming C; Natsugoe S; Takao S; Hokita S; Ishigami S; Tanabe G; Baba M; Kuroshima K; Aikou T Clin Cancer Res; 2001 Feb; 7(2):277-82. PubMed ID: 11234879 [TBL] [Abstract][Full Text] [Related]
11. The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas. Qi Y; Wang CC; He YL; Zou H; Liu CX; Pang LJ; Hu JM; Jiang JF; Zhang WJ; Li F Int J Clin Exp Pathol; 2013; 6(12):2787-99. PubMed ID: 24294365 [TBL] [Abstract][Full Text] [Related]
12. Role of tumor-associated macrophages in the Hexim1 and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma. Ok Atılgan A; Özdemir BH; Akçay EY; Ataol Demirkan Ö; Tekindal MA; Özkardeş H Pathol Res Pract; 2016 Feb; 212(2):83-92. PubMed ID: 26608417 [TBL] [Abstract][Full Text] [Related]
13. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625 [TBL] [Abstract][Full Text] [Related]
14. [Changes in TGF-beta1/Smads signaling pathway in rats with chemical hepatocarcinogenesis]. Hua YP; Li SQ; Lai JM; Liang LJ; Peng BG; Liang HZ; Huang JF Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1848-52. PubMed ID: 18971187 [TBL] [Abstract][Full Text] [Related]
15. The predictive value of genes of the TGF-beta1 pathway in multimodally treated squamous cell carcinoma of the esophagus. Pühringer-Oppermann F; Sarbia M; Ott N; Brücher BL Int J Colorectal Dis; 2010 Apr; 25(4):515-21. PubMed ID: 20012971 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma. Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619 [TBL] [Abstract][Full Text] [Related]
17. MIR-27a regulates the TGF-β signaling pathway by targeting SMAD2 and SMAD4 in lung cancer. Chae DK; Ban E; Yoo YS; Kim EE; Baik JH; Song EJ Mol Carcinog; 2017 Aug; 56(8):1992-1998. PubMed ID: 28370334 [TBL] [Abstract][Full Text] [Related]
18. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway. Yang HJ; Liu GL; Liu B; Liu T J Cell Mol Med; 2018 Mar; 22(3):1650-1665. PubMed ID: 29349903 [TBL] [Abstract][Full Text] [Related]
19. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC; de Caestecker MP; Schnaper HW Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488 [TBL] [Abstract][Full Text] [Related]
20. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis. Yasutome M; Gunn J; Korc M Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]